Commonwealth Equity Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,019
Closed -$1.84M 3717
2021
Q2
$1.84M Sell
10,019
-296
-3% -$54.4K ﹤0.01% 1483
2021
Q1
$1.58M Sell
10,315
-3,518
-25% -$538K ﹤0.01% 1486
2020
Q4
$2.16M Buy
13,833
+613
+5% +$95.8K 0.01% 1181
2020
Q3
$1.51M Buy
13,220
+1,751
+15% +$200K 0.01% 1250
2020
Q2
$1.29M Buy
11,469
+500
+5% +$56.1K ﹤0.01% 1268
2020
Q1
$984K Buy
10,969
+4,075
+59% +$366K ﹤0.01% 1277
2019
Q4
$745K Buy
6,894
+180
+3% +$19.5K ﹤0.01% 1616
2019
Q3
$657K Sell
6,714
-43
-0.6% -$4.21K ﹤0.01% 1631
2019
Q2
$885K Buy
6,757
+55
+0.8% +$7.2K ﹤0.01% 1420
2019
Q1
$905K Sell
6,702
-620
-8% -$83.7K ﹤0.01% 1366
2018
Q4
$712K Buy
7,322
+45
+0.6% +$4.38K ﹤0.01% 1406
2018
Q3
$1.01M Sell
7,277
-440
-6% -$61.1K ﹤0.01% 1293
2018
Q2
$958K Buy
7,717
+81
+1% +$10.1K 0.01% 1306
2018
Q1
$851K Sell
7,636
-102
-1% -$11.4K ﹤0.01% 1350
2017
Q4
$925K Buy
7,738
+194
+3% +$23.2K 0.01% 1265
2017
Q3
$1.06M Sell
7,544
-52
-0.7% -$7.29K 0.01% 1158
2017
Q2
$924K Buy
7,596
+4,393
+137% +$534K 0.01% 1184
2017
Q1
$388K Sell
3,203
-592
-16% -$71.7K ﹤0.01% 1682
2016
Q4
$464K Buy
3,795
+58
+2% +$7.09K ﹤0.01% 1451
2016
Q3
$458K Sell
3,737
-318
-8% -$39K ﹤0.01% 1435
2016
Q2
$473K Buy
4,055
+281
+7% +$32.8K ﹤0.01% 1390
2016
Q1
$525K Sell
3,774
-72
-2% -$10K ﹤0.01% 1292
2015
Q4
$734K Buy
3,846
+94
+3% +$17.9K 0.01% 1087
2015
Q3
$587K Sell
3,752
-2,028
-35% -$317K 0.01% 1164
2015
Q2
$1.05M Buy
5,780
+423
+8% +$76.5K 0.01% 929
2015
Q1
$928K Buy
5,357
+174
+3% +$30.1K 0.01% 995
2014
Q4
$959K Sell
5,183
-1,341
-21% -$248K 0.01% 917
2014
Q3
$1.08M Buy
6,524
+339
+5% +$56.2K 0.01% 831
2014
Q2
$966K Buy
6,185
+16
+0.3% +$2.5K 0.01% 885
2014
Q1
$938K Sell
6,169
-1,944
-24% -$296K 0.01% 831
2013
Q4
$1.08M Buy
8,113
+5,749
+243% +$764K 0.02% 733
2013
Q3
$275K Sell
2,364
-370
-14% -$43K ﹤0.01% 1430
2013
Q2
$252K Buy
+2,734
New +$252K ﹤0.01% 1421